AYAL Capital Advisors Ltd Trims Stock Holdings in Calumet, Inc. $CLMT

AYAL Capital Advisors Ltd reduced its position in Calumet, Inc. (NASDAQ:CLMT) by 53.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 195,000 shares of the oil and gas company’s stock after selling 221,645 shares during the quarter. Calumet makes up approximately 1.4% of AYAL Capital Advisors Ltd’s portfolio, making the stock its 24th biggest position. AYAL Capital Advisors Ltd’s holdings in Calumet were worth $3,875,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Islay Capital Management LLC acquired a new position in shares of Calumet during the fourth quarter worth about $25,000. Aster Capital Management DIFC Ltd grew its holdings in Calumet by 294.7% in the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after purchasing an additional 1,229 shares during the last quarter. Global Retirement Partners LLC acquired a new stake in Calumet in the fourth quarter valued at $34,000. Covestor Ltd grew its holdings in Calumet by 29.1% in the fourth quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock valued at $43,000 after purchasing an additional 492 shares during the last quarter. Finally, CWM LLC boosted its stake in shares of Calumet by 149,900.0% during the fourth quarter. CWM LLC now owns 3,000 shares of the oil and gas company’s stock valued at $60,000 after acquiring an additional 2,998 shares during the last quarter. 34.41% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, major shareholder Group Heritage sold 626,998 shares of Calumet stock in a transaction on Friday, May 15th. The stock was sold at an average price of $32.54, for a total value of $20,402,514.92. Following the transaction, the insider directly owned 12,980,211 shares in the company, valued at $422,376,065.94. The trade was a 4.61% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Daniel J. Sajkowski sold 3,310 shares of Calumet stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $34.46, for a total value of $114,062.60. Following the transaction, the director owned 81,958 shares in the company, valued at $2,824,272.68. This represents a 3.88% decrease in their position. The SEC filing for this sale provides additional information. 4.07% of the stock is currently owned by insiders.

Calumet Trading Up 1.4%

Shares of CLMT opened at $33.15 on Thursday. The firm has a market cap of $2.89 billion, a price-to-earnings ratio of -15.35 and a beta of 0.73. Calumet, Inc. has a 52 week low of $12.94 and a 52 week high of $38.75. The stock has a 50 day moving average of $33.45 and a 200-day moving average of $27.71.

Calumet (NASDAQ:CLMT) last announced its quarterly earnings results on Friday, May 8th. The oil and gas company reported ($3.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by ($3.31). The company had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1 billion. The company’s revenue was up 3.6% on a year-over-year basis. During the same quarter last year, the business posted ($1.87) earnings per share. On average, sell-side analysts predict that Calumet, Inc. will post -0.28 earnings per share for the current fiscal year.

Analysts Set New Price Targets

CLMT has been the topic of several recent analyst reports. The Goldman Sachs Group downgraded Calumet from a “buy” rating to a “neutral” rating and set a $36.00 target price on the stock. in a research report on Friday, April 24th. TD Cowen restated a “hold” rating on shares of Calumet in a report on Wednesday, June 3rd. Weiss Ratings upgraded Calumet from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, May 11th. Finally, HC Wainwright increased their target price on Calumet from $33.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, March 30th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $36.75.

Calumet Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.